NIS2+
LIVE

Serial Number

79361418

Owner

GENFIT

Attorney

Ronald M. Kachmarik

Filing Date

Dec 12, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NIS2+ Trademark

Serial Number: 79361418 • Registration: 7312538

NIS2+ is a trademark filed by GENFIT on December 12, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENFIT (44 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

December 12, 2022

Registration Date

February 27, 2024

Published for Opposition

December 12, 2023

Goods & Services

Pharmaceutical preparations for the prevention and treatment of metabolic disorders and liver diseases; diagnostic preparations and diagnostic bio-marking reagents for medical use; diagnostic testing materials for medical use namely, diagnostic reagents and assays for testing of bodily fluids; blood for medical use and blood-derived samples for medical use, namely, blood substitutes for human use, blood plasma

Diagnostic preparations for industrial and scientific use; chemical reagents for industrial use; chemical reagents for scientific use

Medical analysis for the diagnosis and treatment of persons; medical analysis of blood samples; medical assistance services relating to medicine and health care; medical information; provision of medical information

Scientific and technological services, namely, scientific research in the field of metabolic disorders and liver diseases; biological research; clinical research namely, scientific research in the field of metabolic disorders and liver diseases and medical research; industrial analysis in the nature of analysis of industrial fluids and industrial research services in the field of pharmaceuticals; design and development of computer hardware and software; computers programming; research laboratory in the nature of laboratory research services relating to pharmaceuticals

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 19, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 28, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 7, 2024 FICS
FINAL DISPOSITION PROCESSED
Jul 7, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 27, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 27, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 12, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 12, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Dec 11, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 22, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2023 CNSA
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 13, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 29, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 29, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 17, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 16, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 2, 2023 REPR